On May 20, POET Technologies rose 8.49% in pre-market trading, trading at $14.18 USD/share, with trading volume of approximately $5.68 million. The rebound follows a steep multi-day selloff that took shares from above $23 to below $15 over the prior week.

The recovery is driven by growing market confidence after a bearish short-seller report from NMR was largely debunked over the weekend, with independent verification confirming the company's operational presence and legitimacy. Additionally, the completion of a $400 million registered direct offering to a single institutional investor at $21 per share — a premium to the May 14 closing price — continues to serve as a credibility anchor. The offering included approximately 19 million common shares and equal warrants exercisable at $26.25 over three years, with proceeds earmarked for manufacturing expansion, R&D scaling, and commercialization of optical engine technologies for AI and data center applications.

The stock had previously surged over 43% on a $50 million order from Lumilens before retreating sharply on dilution concerns and the short report. Market participants appear to be re-establishing positions as the fundamental narrative around AI-driven photonic demand remains intact.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)